Tanner Pharma Group to Attend Pharmagora, PQMD, CPhI, US GCSG, and Asembia Conferences
For Immediate Release
Tanner Pharma Group
CHARLOTTE, N.C. – Key directors from Tanner Pharma Group (“Tanner Pharma”), a Charlotte-based global pharmaceutical services company, will attend several healthcare conferences throughout the upcoming month of April. The team will join other global executives for the following events:
Pharmagora | April 7th – 8th | Paris, France
PQMD Global Health Policy Forum | April 11th – 12th | Washington, D.C.
CPhI North America | April 24th – 26th | Philadelphia, PA
US GCSG Conference | April 29th – May 2nd | Atlanta, GA
Asembia’s Specialty Pharmacy Summit | April 29th – May 2nd | Las Vegas, NV.
Tanner Pharma leverages more than 15 years of pharma services experience to provide regulatory compliance and logistical efficiency, all within an EU-GDP compliant supply chain. The company provides services through four synergistic divisions located in the U.S. and U.K.; TannerCTS, clinical trial services; TannerLAC, licensing, acquisition and commercialization; TannerGAP, global access programs; and TannerMAP, managed access programs.
Tanner Pharma representatives will include Richard Lambie, Global Director for TannerCTS, Jonathan Bracey, Managing Director UK – SVP of Corporate Development, and Rob Keel, Director for TannerMAP.
Individuals who wish to schedule a meeting with representatives from Tanner Pharma may contact:
Diana Mendoza | firstname.lastname@example.org | +1 704 552 8408